TY - JOUR
T1 - The COVID-19 pandemic
T2 - A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global
AU - Sullivan, Michael
AU - Bouffet, Eric
AU - Rodriguez-Galindo, Carlos
AU - Luna-Fineman, Sandra
AU - Khan, Muhammad Saghir
AU - Kearns, Pam
AU - Hawkins, Douglas S
AU - Challinor, Julia
AU - Morrissey, Lisa
AU - Fuchs, Jörg
AU - Marcus, Karen
AU - Balduzzi, Adriana
AU - Basset-Salom, Luisa
AU - Caniza, Miguela
AU - Baker, Justin N
AU - Kebudi, Rejin
AU - Hessissen, Laila
AU - Sullivan, Richard
AU - Pritchard-Jones, Kathy
AU - Contributing Authors
A2 - Schmiegelow, Kjeld
N1 - © 2020 Wiley Periodicals, Inc.
PY - 2020/7
Y1 - 2020/7
N2 - The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low- and middle-income countries. Therefore, we have brought together the relevant clinical leads from SIOP Europe, COG, and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g., extreme social distancing), and how to prepare for the anticipated recovery period.
AB - The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low- and middle-income countries. Therefore, we have brought together the relevant clinical leads from SIOP Europe, COG, and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g., extreme social distancing), and how to prepare for the anticipated recovery period.
KW - Betacoronavirus
KW - COVID-19
KW - Child
KW - Consensus
KW - Coronavirus Infections/epidemiology
KW - Disease Management
KW - Humans
KW - Medical Oncology
KW - Neoplasms/complications
KW - Pandemics
KW - Pediatrics
KW - Pneumonia, Viral/epidemiology
KW - SARS-CoV-2
KW - Societies, Medical
U2 - 10.1002/pbc.28409
DO - 10.1002/pbc.28409
M3 - Journal article
C2 - 32400924
SN - 1545-5009
VL - 67
SP - e28409
JO - Pediatric Blood & Cancer
JF - Pediatric Blood & Cancer
IS - 7
ER -